Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toby N Trahair

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Nature Medicine|June 6, 2024
Precision-guided treatment in high-risk pediatric cancersLoretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancerNoemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh, et al.
EMBO Molecular Medicine|December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancerLoretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Nature Medicine|October 6, 2020
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancerMarie Wong, Chelsea Mayoh, Loretta M S Lau, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Nature Medicine|June 6, 2024
Precision-guided treatment in high-risk pediatric cancersLoretta M S Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2026
Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancerNoemi A Fuentes-Bolanos, Eliza Courtney, Chelsea Mayoh, et al.
EMBO Molecular Medicine|December 20, 2021
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancerLoretta M S Lau, Chelsea Mayoh, Jinhan Xie, et al.
Nature Medicine|October 6, 2020
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancerMarie Wong, Chelsea Mayoh, Loretta M S Lau, et al.
Pageof 6